Yu Liang

Yu Liang

Company: Compugen

Job title: Director - Clinical Biomarker


Panel Discussion: Moving the Dial Toward Greater Equity, Diversity & Inclusivity (ED&I) in Precision Oncology Clinical Research; a Focus on Clinical Trials Incorporating Liquid Biopsies 9:30 am

Shaping the importance of improving ED&I within clinical studies to optimize clinical care and innovation Discussing contributions towards racial and ethnic disparities in clinical trials where liquid biopsies are used as novel tools in precision oncology Catalyzing new guidelines to deliver on the promise of improving integrity, safety and rigor of global clinical trialsRead more

day: Day One

Panel Discussion: Reshaping the Bioinformatic Pipelines in Early Translation for Enhanced Therapeutic Efficacy of Liquid Biopsy Approaches 12:30 pm

Discussing the opportunities and challenges of bioinformatics to demonstrate analytical validity Evaluating the prediction of disease diagnosis, detection and monitoring of liquid biopsy using novel bioinformatic techniques Accelerating the discovery of novel oncology targets using advanced bioinformatic pipelines incorporating real-life data and real-world evidence (RWE) Developing advanced computational models to improve and validate results from…Read more

day: Day One Track A AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.